Insider trades
Joshua T. Brumm, CEO of Crescent Biopharma CBIO, has filed 0 purchases and 26 sales on the open market. Over the past 12 months that comes to a net sale of $761.1K. The latest trade was on 06/22.
Joshua T. Brumm
CEO
- Company
- Crescent Biopharma CBIO
- First filing
- 23/03/15
- Trades
- 59 trades
- Buys / sales
- 0 / 26
- 12-month net buying
- −$761.1K
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/22 | 06/23 | 42,305 sh | $17.99 | $761,066.95 | −13.1% | |
DYN | Open-market sale10b5-1 plan | 24/03/08–24/03/11 | 24/03/12 | 429,730 sh7 trades | $25.89avg. | $11,125,776.16 | −44.4% |
| Open-market sale10b5-1 plan | 24/03/07 | 24/03/11 | 9,086 sh | $25.85 | $234,873.1 | −1.6% | |
DYN | Open-market sale10b5-1 plan | 24/02/29–24/03/01 | 24/03/01 | 100,000 sh4 trades | $28.96avg. | $2,895,518.5 | −15.1% |
DYN | Open-market sale10b5-1 plan | 24/01/03–24/01/04 | 24/01/04 | 269,719 sh5 trades | $18.66avg. | $5,032,915.18 | −31.6% |
| Open-market sale | 23/12/11 | 23/12/12 | 7,585 sh | $10.72 | $81,311.2 | −1.3% | |
| Open-market sale | 23/09/18 | 23/09/20 | 12,032 sh | $9.41 | $113,221.12 | −4.9% | |
| Open-market sale | 23/09/12 | 23/09/13 | 7,672 sh | $10.41 | $79,865.52 | −3.0% | |
DYN | Open-market sale | 23/06/08–23/06/12 | 23/06/12 | 325,330 sh4 trades | $12.90avg. | $4,195,796.64 | −56.2% |
| Open-market sale | 23/03/14 | 23/03/15 | 7,318 sh | $13.33 | $97,548.94 | −2.2% |
